Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Eber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Infection Control and Hospital Epidemiology|December 25, 2009
Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006Marc S Hoffmann, Michael R Eber, Ramanan Laxminarayan
Journal of Benefit-Cost Analysis|September 12, 2022
Valuing COVID-19 Morbidity Risk ReductionsLisa A Robinson, Michael R Eber, James K Hammitt
Archives of Internal Medicine|February 24, 2010
Clinical and economic outcomes attributable to health care-associated sepsis and pneumoniaMichael R Eber, Ramanan Laxminarayan, Eli N Perencevich, et al.
Journal of Risk and Uncertainty|August 13, 2021
The Modest Effects of Fact Boxes on Cancer ScreeningMichael R Eber, Cass R Sunstein, James K Hammitt, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 17, 2023
The benefits and costs of U.S. employer COVID-19 vaccine mandatesMaddalena Ferranna, Lisa A Robinson, Daniel Cadarette, et al.
Plos One|October 4, 2011
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patientsMichael R Eber, Michelle Shardell, Marin L Schweizer, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010Nikolay P Braykov, Michael R Eber, Eili Y Klein, et al.
Antimicrobial Resistance and Infection Control|October 17, 2013
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infectionsMarin L Schweizer, Eli N Perencevich, Michael R Eber, et al.
The American Journal of Managed Care|June 4, 2013
Measuring the value of better diabetes managementDarius Lakdawalla, Michael R Eber, Felicia M Forma, et al.
American Heart Journal|September 11, 2013
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillationMintu P Turakhia, Matthew D Solomon, Mehul Jhaveri, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Infection Control and Hospital Epidemiology|December 25, 2009
Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006Marc S Hoffmann, Michael R Eber, Ramanan Laxminarayan
Journal of Benefit-Cost Analysis|September 12, 2022
Valuing COVID-19 Morbidity Risk ReductionsLisa A Robinson, Michael R Eber, James K Hammitt
Archives of Internal Medicine|February 24, 2010
Clinical and economic outcomes attributable to health care-associated sepsis and pneumoniaMichael R Eber, Ramanan Laxminarayan, Eli N Perencevich, et al.
Journal of Risk and Uncertainty|August 13, 2021
The Modest Effects of Fact Boxes on Cancer ScreeningMichael R Eber, Cass R Sunstein, James K Hammitt, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 17, 2023
The benefits and costs of U.S. employer COVID-19 vaccine mandatesMaddalena Ferranna, Lisa A Robinson, Daniel Cadarette, et al.
Plos One|October 4, 2011
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patientsMichael R Eber, Michelle Shardell, Marin L Schweizer, et al.
Infection Control and Hospital Epidemiology|February 8, 2013
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010Nikolay P Braykov, Michael R Eber, Eili Y Klein, et al.
Antimicrobial Resistance and Infection Control|October 17, 2013
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infectionsMarin L Schweizer, Eli N Perencevich, Michael R Eber, et al.
The American Journal of Managed Care|June 4, 2013
Measuring the value of better diabetes managementDarius Lakdawalla, Michael R Eber, Felicia M Forma, et al.
American Heart Journal|September 11, 2013
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillationMintu P Turakhia, Matthew D Solomon, Mehul Jhaveri, et al.
Pageof 2